In vitro selection analysis of neomycin binding RNAs with a mutagenized pool of variants of the 16S rRNA decoding region

Biochemistry
M Famulok, A Hüttenhofer

Abstract

An in vitro selection for neomycin B binding was carried out with an RNA pool containing a 47-nucleotide domain of the decoding region of 16S ribosomal RNA, mutated at 30% per base position. The degenerate region was comprised of an oligonucleotide analogue ("motif A") of the decoding region in 30S subunits which has previously been shown to interact with the aminoglycoside antibiotic neomycin B and tRNA ligands. After five cycles of selection/amplification, RNA sequences were isolated which specifically bound to neomycin B. Cloning and sequencing showed that none of the isolated clones shared primary sequence or secondary structure homology with the decoding region of 16S RNA. Instead, a new set of sequences was isolated which could be folded into a defined hairpin structure designated as motif B. We investigated the affinity of motif A, motif B, the unselected pool RNA, and the corresponding unmutagenized "parent" RNA to neomycin B at different Mg2+ concentrations. Under buffer conditions of low ionic strength all RNAs tested bound nonspecifically to neomycin B. However, motif B bound to neomycin B at Mg2+ concentrations at which binding of the other RNAs tested was significantly lower or not detectable. This is consistent wi...Continue Reading

References

Aug 20, 1992·Journal of Molecular Biology·U von AhsenR Schroeder
Jan 1, 1995·Annual Review of Biochemistry·L GoldM Yarus

❮ Previous
Next ❯

Citations

May 20, 1999·Biopolymers·T Hermann, E Westhof
Feb 22, 2012·Analytical and Bioanalytical Chemistry·Ilaria Palchetti, Marco Mascini
Jun 13, 2013·Bioorganic & Medicinal Chemistry·Björn NiebelMichael Famulok
Jan 1, 1997·Progress in Biophysics and Molecular Biology·M G Wallis, R Schroeder
Mar 21, 1998·Current Opinion in Biotechnology·T Hermann, E Westhof
Sep 15, 2001·Bioorganic & Medicinal Chemistry·D H Ryu, R R Rando
Oct 28, 1999·Nucleic Acids Research·V BourdeauR Cedergren
Nov 25, 2014·Mikrochimica Acta·Jingjing WuWei Chen
Mar 26, 2009·Angewandte Chemie·Günter Mayer
Aug 7, 2010·Chemistry : a European Journal·Björn NiebelMichael Famulok
Jan 4, 2012·Angewandte Chemie·Marco MasciniSara Tombelli
Apr 21, 1999·Carbohydrate Research·M Jezowska-BojczukH Kozłowski
Jun 11, 1999·Current Opinion in Structural Biology·M Famulok
Jan 22, 2013·Cell·Xu JiaAlastair I H Murchie
Feb 28, 2009·Chemistry & Biology·Anke HunsickerBeatrix Suess
Jun 6, 2006·Advances in Carbohydrate Chemistry and Biochemistry·Bert Willis, Dev P Arya
May 13, 2014·Journal of Molecular Biology·Xiancheng ZengCharles L Brooks
Dec 3, 2014·Cell Reports·Carrie L SimmsHani S Zaher
Nov 14, 1997·Journal of Molecular Biology·C SpicklerL Brakier-Gingras
Mar 28, 2013·International Journal of Molecular Sciences·Andrea ConidiDanny Huylebroeck
Aug 14, 2020·The FEBS Journal·Jun ZhangAlastair I H Murchie
Mar 6, 2012·Bioanalytical Reviews·Beate StrehlitzRegina Stoltenburg
Mar 2, 2019·Communications Biology·Chao QinYanzheng Gao
Aug 5, 1997·Chemical Reviews·Christine S. Chow, Felicia M. Bogdan
Sep 20, 2000·Accounts of Chemical Research·M FamulokM Blind
Apr 10, 1999·Journal of Medicinal Chemistry·T Hermann, E Westhof
Nov 3, 2009·Journal of Medicinal Chemistry·Michael Famulok
Oct 29, 1997·Journal of Virology·S WeissE L Winnacker
Apr 1, 1997·Chemical Reviews·Scott E. Osborne, Andrew D. Ellington
Sep 13, 2017·Biochemistry·Lizzette M Gómez RamosLoren Dean Williams
Apr 23, 1997·Journal of the American Chemical Society·M HendrixC H Wong
Feb 5, 2000·Science·T Hermann, D J Patel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.